BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)
Clinical trial NCT00605215 · COMPLETED
Trial details
- NCT number
- NCT00605215
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-04-24
- Primary completion
- 2011-06-10
- Enrollment
- 1331
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.